Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting.

导出 LinkOut

翻译打印收藏纠错

第一作者： Eric,Senbel

第一单位： Rheumatology Office, Marseille, France.

作者： Eric,Senbel ^[1] ; Sonia,Tropé ^[2] ; Hélène,Herman-Demars ^[3] ; Elena,Zinovieva ^[3] ; Agnès,Courbeyrette ^[3] ; Pierre,Clerson ^[4] ; Yann,Fardini ^[4] ; René-Marc,Flipo ^[5]

作者单位： Rheumatology Office, Marseille, France. ^[1] French National Patient Organization Against Rheumatoid Arthritis (ANDAR), Montpellier, France. ^[2] Medical Department, Nordic Pharma, Paris, France. ^[3] Soladis Clinical Studies, Roubaix, France. ^[4] University of Lille, Rheumatology Department, Hôpital Roger Salengro, Lille, France. ^[5]

关键词 compliance methotrexate oral rheumatoid arthritis subcutaneous switch

DOI 10.2147/PPA.S301010

PMID 33888978

发布时间 2022-04-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Patient preference and adherence

2021年15卷

751-760页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting.

Patient preference and adherence

相似文献

Patient preference and adherence

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting.

Patient preference and adherence

相似文献

Patient preference and adherence

相关期刊

检索历史清除